Urticarial vasculitis: a unique presentation.
Urticarial vasculitis is a relatively rare diagnosis in a patient presenting with urticaria. The process is classically described as a generalized eruption, painful more so than pruritic, lasting longer than 24 hours. Two forms of urticarial vasculitis have been described: ahypocomplementemic form more commonly associated with systemic disease, and a normocomplementemic form that is generally limited to the skin. We report on a uniquely distributed vasculitic eruption restricted mainly to the anterior belt line area in a patient presenting with urticaria and intense pruritus. Urticarial vasculitis as a unique entity is reviewed along with its clinical and histopathologic presentation and the pharmacologic agents used for treatment.
Division of Dermatology, Department of Internal Medicine, East Tennessee State University Quillen College of Medicine, 1809 West Lakeview Drive #21, Johnson City, TN 37601, USA. lstigall2@gmail.com
Landon E
LE
Stigall
Justin R
JR
Sigmon
Stuart S
SS
Leicht
D000328:Adult; D000730:Androstadienes / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068298:Fluticasone; D006801:Humans; D008297:Male; D009450:Neurodermatitis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy / Q000209:etiology*; D014581:Urticaria / Q000188:drug therapy / Q000209:etiology*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy*
D000730:Androstadienes; D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D000068298:Fluticasone; D003078:Colchicine; D011241:Prednisone